BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9184676)

  • 1. The role of platelet-activating factor in conscious, normotensive endotoxemia.
    Ephgrave K; Kremer T; Broadhurst K; Cullen J
    J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C; Guc MO; Furman BL; Parratt JR
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-hydroxyeicosatetraenoic acids during porcine endotoxemia. Effect of a platelet-activating factor receptor antagonist.
    Olson NC; Joyce PB; Fleisher LN
    Lab Invest; 1990 Aug; 63(2):221-32. PubMed ID: 2116563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonists in experimental shock.
    Muacevic G; Heuer HO
    Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats.
    Mulder MF; van Lambalgen AA; van Kraats AA; Scheffer PG; Bouman AA; van den Bos GC; Thijs LG
    Circ Shock; 1993 Dec; 41(4):221-9. PubMed ID: 8143350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO; Letts G; Meade CJ
    J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
    Yue TL; Farhat M; Rabinovici R; Perera PY; Vogel SN; Feuerstein G
    J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent ulcerogenic actions of platelet-activating factor on the stomach.
    Rosam AC; Wallace JL; Whittle BJ
    Nature; 1986 Jan 2-8; 319(6048):54-6. PubMed ID: 3510396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on the relation of platelet activating factor (PAF) to high mortality in sublethal endotoxemia after massive hepatectomy and effects of its antagonist].
    Onuki Y; Nakamura S; Muro H; Baba S
    Nihon Geka Gakkai Zasshi; 1993 May; 94(5):466-74. PubMed ID: 8332121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenetic effect of platelet activating factor on enterogenic endotoxemia after burn].
    Yu P; Xiao G; Fu W
    Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):136-8. PubMed ID: 11601022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog.
    Chu KM; Gerber JG; Nies AS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):996-1000. PubMed ID: 3418522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
    Chang SW; Feddersen CO; Henson PM; Voelkel NF
    J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge.
    Corl CM; Contreras GA; Sordillo LM
    Vet Immunol Immunopathol; 2010 Jul; 136(1-2):98-107. PubMed ID: 20359754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.